313 related articles for article (PubMed ID: 34206143)
1.
Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
[TBL] [Abstract][Full Text] [Related]
2. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
4. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of
Huang YH; Lian WS; Wang FS; Wang PW; Lin HY; Tsai MC; Yang YL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163556
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase assists tumor‑initiating cells to enhance angiogenesis in hepatocellular carcinoma.
Yang M; Liu J; Wang F; Tian Z; Ma B; Li Z; Wang B; Zhao W
Int J Oncol; 2019 Apr; 54(4):1398-1408. PubMed ID: 30720077
[TBL] [Abstract][Full Text] [Related]
6. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells.
Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q
Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑302a inhibits cell proliferation and invasion, and induces cell apoptosis in hepatocellular carcinoma by directly targeting VEGFA.
Qin C; Zha W; Fan R; Ding H; Xu Y; Wang C
Mol Med Rep; 2017 Nov; 16(5):6360-6367. PubMed ID: 28849033
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.
Umezaki N; Nakagawa S; Yamashita YI; Kitano Y; Arima K; Miyata T; Hiyoshi Y; Okabe H; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Cancer Sci; 2019 Jun; 110(6):2033-2043. PubMed ID: 30919528
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract][Full Text] [Related]
10. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-29a suppressed the migration and invasion of trophoblasts by directly targeting LOXL2 in preeclampsia.
Xu XH; Tang LC; Hao F; Jin LP
J Hypertens; 2021 Aug; 39(8):1642-1651. PubMed ID: 33657581
[TBL] [Abstract][Full Text] [Related]
12. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
13. miR‑29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3.
Liang Y; Li E; Min J; Gong C; Gao J; Ai J; Liao W; Wu L
Oncol Rep; 2018 Dec; 40(6):3261-3272. PubMed ID: 30272306
[TBL] [Abstract][Full Text] [Related]
14. miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19.
Yao X; Zhang H; Liu Y; Liu X; Wang X; Sun X; Cheng Y
Gene; 2019 May; 698():141-149. PubMed ID: 30849536
[TBL] [Abstract][Full Text] [Related]
15. HANR promotes lymphangiogenesis of hepatocellular carcinoma via secreting miR-296 exosome and regulating EAG1/VEGFA signaling in HDLEC cells.
Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
J Cell Biochem; 2019 Oct; 120(10):17699-17708. PubMed ID: 31127654
[TBL] [Abstract][Full Text] [Related]
16. The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.
Peng T; Deng X; Tian F; Li Z; Jiang P; Zhao X; Chen G; Chen Y; Zheng P; Li D; Wang S
Int J Oncol; 2019 Sep; 55(3):657-670. PubMed ID: 31322171
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
[TBL] [Abstract][Full Text] [Related]
18. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
[TBL] [Abstract][Full Text] [Related]
20. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA.
Cui W; Li Y; Xu K; Chen G; Lu X; Duan Q; Kang Z
Biochem Biophys Res Commun; 2016 Oct; 479(4):901-906. PubMed ID: 27641667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]